<PAGE> 1
FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarter ended: March 31, 2000
Commission file number: 33-20323
Royal BodyCare, Inc.
--------------------
(Exact name of registrant as specified in its charter)
Nevada 91-2015186
- ------------------------ ---------------------
(State of Incorporation) (IRS Employer ID No.)
2301 Crown Court, Irving, Texas 75038
------------------------------- -----
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: 972-893-4000
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by section 13 or 15(d) of the Securities Act of 1934 during the past
12 months and (2) has been subject to such filing requirements for the past 90
days.
[X] YES [ ] NO
Shares of common stock outstanding at May 12, 2000:
13,916,294
<PAGE> 2
TABLE OF CONTENTS
<TABLE>
PART I - FINANCIAL INFORMATION Page Number
<S> <C> <C> <C>
Item 1. Financial Statements
Condensed Consolidated Balance Sheets
as of March 31, 2000 and December 31, 1999 3
Condensed Consolidated Statements of
Operations for the quarters ended March 31, 2000
and 1999 4
Condensed Consolidated Statements of
Cash Flows for the quarters ended March 31, 2000
and 1999 5
Notes to Condensed Consolidated Financial
Statements 6
Item 2. Management's Discussion and Analysis
of Financial Condition and Results of
Operations 11
Item 3. Quantitative and Qualitative Disclosure about
Market Risk 13
PART II - OTHER INFORMATION
Item 1. Legal Proceedings 14
Item 2. Changes in Securities 14
Item 3. Defaults Upon Senior Securities 14
Item 4. Submission of Matters to a Vote of Security
Holders 14
Item 5. Other Information 14
Item 6. Exhibits and Reports on Form 8-K 14
</TABLE>
<PAGE> 3
ITEM 1. FINANCIAL STATEMENTS
ROYAL BODYCARE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
<TABLE>
<CAPTION>
MARCH 31, DECEMBER 31,
2000 1999
------------ ------------
<S> <C> <C>
ASSETS
Current assets:
Cash $ 585,228 $ 208,225
Accounts receivable 633,383 542,191
Inventories 3,321,838 2,904,603
Deferred tax asset 170,981 248,981
Prepaids and other 80,588 75,465
------------ ------------
Total current assets 4,792,018 3,979,465
Property & equipment, net 2,348,496 2,185,617
Goodwill, net 2,475,937 2,516,945
Other assets 334,864 318,369
------------ ------------
$ 9,951,315 $ 9,000,396
============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Current portion of long term debt $ 692,651 $ 671,806
Notes payable 107,835 108,071
Accounts payable 1,281,069 944,071
Accrued liabilities 2,338,907 2,059,495
Net liabilities of discontinued operations 212,386 212,386
------------ ------------
Total current liabilities 4,632,848 3,995,829
Long term debt, net of current portion 746,168 584,980
Deferred tax liability, non-current 31,535 31,535
Shareholders' equity:
Common stock, $0.001 par value;
50,000,000 shares authorized;
13,916,294 shares issued and
outstanding 13,916 13,916
Paid in capital 12,147,818 12,147,818
Accumulated deficit (7,634,425) (7,785,407)
Cumulative translation adjustment 13,455 11,725
------------ ------------
4,540,764 4,388,052
------------ ------------
$ 9,951,315 $ 9,000,396
============ ============
</TABLE>
See notes to condensed consolidated financial statements.
-3-
<PAGE> 4
ROYAL BODYCARE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>
For the Quarter Ended March 31,
-------------------------------
2000 1999
----------- -----------
<S> <C> <C>
Sales $ 9,390,527 $ 8,141,320
Cost of goods sold 2,293,157 1,965,432
----------- -----------
Gross margin 7,097,370 6,175,888
Operating expenses
Distributor commissions 4,089,878 3,448,486
Selling, general and administrative 2,778,510 2,322,489
----------- -----------
Total operating expenses 6,868,388 5,770,975
----------- -----------
Income before income taxes 228,982 404,913
Provision for income taxes 78,000 190,000
----------- -----------
Income from continuing operations 150,982 214,913
Income from discontinued operations -- 131,433
----------- -----------
Net income $ 150,982 $ 346,346
=========== ===========
Income (loss) per share:
Income from continuing operations per share $ 0.01 $ 0.02
Income from discontinued operations per share -- 0.01
----------- -----------
Net income per share $ 0.01 $ 0.02
=========== ===========
Weighted average common shares outstanding 13,916,294 13,862,205
=========== ===========
</TABLE>
See notes to condensed consolidated financial statements.
-4-
<PAGE> 5
ROYAL BODYCARE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
<TABLE>
<CAPTION>
For the Quarter Ended March 31,
-------------------------------
2000 1999
--------- ---------
<S> <C> <C>
Cash flows from operating activities:
Net income (loss) 150,982 413,346
Add loss from discontinued operations $ -- $(198,433)
--------- ---------
Income (loss) from continuing operations 150,982 214,913
Adjustment for non-cash items:
Depreciation and amortization 149,961 108,054
Deferred income taxes 78,000 69,000
(Increase) decrease in accounts receivable (91,203) (26,546)
(Increase) decrease in inventory (421,085) (45,410)
(Increase) decrease in prepaids and other (5,279) 92,622
(Increase) decrease in other assets (16,495) 14,894
Increase (decrease) in accounts payable
and accrued expenses 618,900 (12,879)
Increase (decrease) in notes payable -- (42,870)
--------- ---------
Cash flows from continuing operations 463,781 371,778
Cash flows from discontinued operations -- --
--------- ---------
Total cash provided by (used for) operating activities 463,781 371,778
--------- ---------
Cash flows from investing activities:
Purchase of property and equipment (150,846) (188,324)
--------- ---------
Total cash provided by (used for) investing activities (150,846) (188,324)
--------- ---------
Cash flows from financing activities:
Proceeds from long term debt 235,641 --
Payments of long term debt and capital leases (173,617) (92,446)
--------- ---------
Total cash provided by (used for) financing activities 62,024 (92,446)
--------- ---------
Effect of exchange rate changes on cash flows 2,044 (262)
--------- ---------
Net increase (decrease) in cash 377,003 90,746
Cash, beginning of period 208,225 382,409
--------- ---------
Cash, end of period $ 585,228 $ 473,155
========= =========
</TABLE>
See notes to condensed consolidated financial statements.
-5-
<PAGE> 6
ROYAL BODYCARE, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 - UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:
The accompanying condensed consolidated financial statements were prepared by us
without audit by independent public accountants. In the opinion of management,
all adjustments have been made that are necessary for a fair presentation of our
results for the interim periods presented. Adjustments made were of a normal and
recurring nature. However, certain disclosures required by generally accepted
accounting principles have been omitted or condensed. The Condensed Consolidated
Balance Sheet as of December 31, 1999 was derived from our audited financial
statements included in our Form 10-K for the year ended December 31, 1999. These
financial statements should be read in conjunction with our Form 10-K for the
year ended December 31, 1999.
NOTE 2 -BUSINESS HISTORY:
HISTORY - In October 1999, we changed our name from GlobeNet International I,
Inc. to Royal BodyCare, Inc. In conjunction with the name change, we also
redomesticated to the State of Nevada.
Our history, and that of our predecessors, is as follows: In February 1988, the
Jason Ray Corporation was organized under Delaware law for the purpose of
combining with other businesses. In April 1988, the Jason Ray Corporation filed
an initial public offering registration statement on Form S-1 with the
Securities and Exchange Commission. The Jason Ray Corporation changed its name
to Seven Oaks Farms, Ltd. on July 1, 1988. From May 1991 until October 1995,
Seven Oaks Farms was a dormant entity, conducting no business activities.
Effective November 1, 1995, Seven Oaks Farms merged with Mighty Power, Inc., a
privately held Oklahoma corporation. The merger, a purchase under Accounting
Principles Board Opinion 16, was accounted for as a reverse merger with Seven
Oaks Farms being the survivor but Mighty Power being treated as the acquirer.
Seven Oaks Farms then changed its name to Mighty Power USA, Inc.
In April 1997, Mighty Power USA, Inc. merged with GlobeNet Inc. This merger,
also a purchase under Accounting Principles Board Opinion 16, was accounted for
as a reverse merger with Mighty Power USA, Inc. being the survivor but GlobeNet
Inc. being treated as the acquirer. Mighty Power USA, Inc. then changed its name
to GlobeNet International I, Inc.
GlobeNet Inc. was incorporated in June 1995, to serve as a holding company for
affiliated corporations owned or controlled by Clinton Howard. In July, 1995,
Mr. Howard and members of his immediate family contributed the stock of these
affiliated corporations to GlobeNet in exchange for shares of its stock.
-6-
<PAGE> 7
Concurrent with the merger of Mighty Power USA and GlobeNet, an affiliate of
Mighty Power USA, Great Xpectations Marketing, Inc., acquired all the assets and
liabilities of two other affiliates of Mighty Power USA for $100,000 in notes
payable. We then purchased all the outstanding common stock of Great Xpectations
for an additional $100,000 note payable. These transactions were also accounted
for as purchases. In June, 1998, we announced our intention to spin off Great
Xpectations to our shareholders. Because Great Xpectations was unable to
adequately execute its business plan and no longer had any meaningful assets, we
subsequently decided to discontinue the planned spin-off of Great Xpectations.
Our 1998 financial statements and our quarterly financial statements for the
first three quarters of 1999 were prepared as if the spinoff of Great
Xpectations had been completed on June 30, 1998. We have restated these
financial statements to reflect our decision to discontinue the planned spin-off
and discontinue Great Xpectations' operations. Accordingly, our financial
statements for the three months ended March 31, 1999 include the accounts of
Great Xpectations, resulting in the addition of income from discontinued
operations of $131,433.
OPERATIONS - We are engaged in the marketing of nutritional supplements and
personal care products through an international network of independent
distributors. We operate our business in the U.S. and Canada through the Royal
BodyCare USA, Inc. and Royal BodyCare Canada, Inc., respectively, and in other
countries through licensees. Our business represents the separate business
strategies and product lines of GlobeNet preceding the merger with Mighty Power
described above. The operations of Mighty Power and its affiliates prior to the
merger with GlobeNet were conducted by Great Xpectations after the merger. As
described above, these operations have been discontinued and are presented as
discontinued operations in the accompanying financial statements.
In 1995, we began entering into agreements to license the exclusive rights to
sell our products through third party licensees in various countries. Since
1995, we have entered into seven such agreements to market our products. Under
these agreements independent distributors in the licensed countries are
compensated according to the same compensation plan as that is used for the
independent distributors in the U.S. and Canada.
NOTE 3 - INVENTORIES:
At March 31, 2000 and December 31, 1999, inventories consist of finished goods,
bulk products ready for packaging and packaging materials.
NOTE 4 - PROPERTY AND EQUIPMENT:
Property and equipment consists of the following:
<TABLE>
<CAPTION>
March 31, 2000 December 31, 1999
-------------- -----------------
<S> <C> <C>
Furniture and fixtures $ 3,162,012 $ 2,900,850
Warehouse equipment 315,675 304,854
Automotive equipment 15,999 15,609
Leasehold improvements 106,524 106,525
----------- -----------
3,600,210 3,327,838
Less - accumulated depreciation (1,251,714) (1,142,221)
----------- -----------
$ 2,348,496 $ 2,185,617
=========== ===========
</TABLE>
-7-
<PAGE> 8
NOTE 5 - GOODWILL:
Goodwill was recorded in connection with the acquisition of Pure Life
International Products, Inc. in 1992 and Light Force, Inc. ("Light Force") in
June 1996 as follows:
<TABLE>
<CAPTION>
March 31, 2000 December 31, 1999
-------------- -----------------
<S> <C> <C>
Light Force $ 2,378,727 $ 2,378,727
Pure Life 843,622 843,622
----------- -----------
3,222,349 3,222,349
Less - accumulated amortization (746,412) (705,404)
----------- -----------
$ 2,475,937 $ 2,516,945
=========== ===========
</TABLE>
NOTE 6 - ACCRUED LIABILITIES:
Accrued liabilities consist of the following:
<TABLE>
<CAPTION>
March 31, 2000 December 31, 1999
-------------- -----------------
<S> <C> <C>
Distributor Commissions $1,827,491 $1,496,558
Sales and other taxes 224,844 165,000
Interest 16,148 12,552
Other 270,424 385,385
---------- ----------
$2,338,907 $2,059,495
========== ==========
</TABLE>
NOTE 7 - LONG TERM DEBT:
Long term obligations consist of the following:
<TABLE>
<CAPTION>
March 31, 2000 December 31, 1999
-------------- -----------------
<S> <C> <C>
Notes payable - banks $ 129,540 $ 146,736
Convertible notes payable 273,000 273,000
Debentures 25,000 25,000
Whigham settlement 289,952 380,248
Capital leases 721,327 431,802
----------- -----------
1,438,819 1,256,786
Less - current portion (692,651) (671,806)
----------- -----------
$ 746,168 $ 584,980
=========== ===========
</TABLE>
Included in notes payable-banks are three notes assumed in connection with the
Light Force acquisition totaling $16,856 and $23,540 at March 31, 2000 and
December 31, 1999, respectively, bearing interest at prime plus 5%, due in
monthly payments aggregating $3,311 plus interest through November 2000. One
note was assumed at the time of the acquisition and two additional notes were
assumed in 1997 in lieu of cash payment for commissions payable.
Included in notes payable-banks are three notes payable totaling $51,917 and
$57,442 at March 31, 2000 and December 31, 1999, respectively for the purchase
of automotive equipment. These notes are payable through 2002, bear interest
ranging from 4.9% to 18%, and are collateralized by the automobiles financed.
-8-
<PAGE> 9
Also included in notes payable-banks is an equipment repurchase note of $60,767
and $65,754 at March 31, 2000 and December 31, 1999, respectively, payable
$2,146 a month, including interest at 9%, through 2002.
In 1997, we sold convertible notes aggregating $730,000. The notes bear interest
at 10% payable quarterly, and were originally due two years from the date of
issuance. The notes are convertible into our common stock at any time prior to
maturity at the option of the holder based on per share conversion price of
$1.32. As of March 31, 2000, we have repaid $209,000 and $248,000 has been
converted into 186,885 shares of our common stock. The remaining notes were
renewed at the option of the holder for periods of one year from the anniversary
of the original due date.
In 1994, we sold two debentures in the amount of $25,000 each, the proceeds of
which were used for working capital. The principal portion of these debentures
was due upon maturity in 1998. In 1997 the 10% Debenture holder exchanged their
Debenture for a convertible note described above. In 1998, the holder of the
other debenture extended the due date by four years. Interest on the debenture
is payable monthly at a rate of 15%.
In 1999 we settled a claim by a former marketing consultant and distributor of
our products ("Whigham Settlement") by agreeing to pay $540,000 over a 54-month
period. The settlement was payable $100,000 in each October, 1999, January, 2000
and April, 2000 and $5,000 a month beginning May, 2000 through April, 2004. The
settlement is without interest and has been discounted at 10%.
Certain purchases of equipment and software have been financed through capital
leases. Such leases have terms ending in 2004 and have various interest rates
approximating 15%.
NOTE 8 - SHAREHOLDERS' EQUITY:
In connection with private placements of its common stock in October, 1997,
June, 1998 and July, 1998, we issued to the purchasers five-year warrants to
purchase an aggregate of 1,216,931 shares of our unregistered common stock at an
exercise price of $2.00 per share. The investors also received certain
registration rights covering the private placement and warrant shares
exercisable under certain circumstances described in the stock purchase
agreements.
In addition, we have granted, to employees and distributors, options to purchase
an additional 1,113,120 shares of unregistered common stock at exercise prices
ranging from $.73 to $2.40 through 2003. All options were issued at or above
market price at the time of issuance.
-9-
<PAGE> 10
NOTE 9 - INCOME TAXES:
We file a consolidated tax return with our U.S. subsidiaries. Our Canadian
subsidiary files a consolidated Canadian tax return with its Canadian
subsidiary.
Deferred income taxes are the result of net operating loss carry-forwards
expected to be fully utilized in the near future and other temporary
differences. We have a net operating loss carryforward of approximately $657,000
that may be used to offset future taxable income. The carryforward will expire
between the years 2013 and 2015.
NOTE 10 - CONTINGENCIES:
From time to time we are involved in various legal matters arising in the normal
course of business. In the opinion of management, any such matters that have
come to our attention are without merit and the outcome will not have a material
effect on our financial position.
-10-
<PAGE> 11
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
FORWARD-LOOKING STATEMENTS
The statements, other than statements of historical facts included in this
report are forward-looking statements. Forward-looking statements generally can
be identified by the use of forward-looking terminology such as "may", "will",
"expect", intend", "estimate", "anticipate" or "believe". We believe that the
expectations reflected in such forward-looking statements are accurate. However,
we cannot assure you that such expectations will occur. Our actual future
performance could differ materially from such statements. Factors that could
cause or contribute to such differences include, but are not limited to:
o general economic conditions
o general market acceptance of our products and distribution methods
o introduction of competitive products
o pricing of competitive products
o regulatory actions effecting the market of our products and distribution
methods
o reduction in demand for our products or the rate at which new distributors
are recruited to join us
o the discontinuance or reduction of the production of Flanagan
Microclusters(R) and Nanocolloidal Hydride, essential ingredients in
certain of our products and which are produced at a single manufacturing
facility
RESULTS OF OPERATIONS
Quarter Ended March 31, 2000 Compared with the Quarter Ended March 31, 1999
Our sales for the quarter ended March 31, 2000 were $9,391,000 compared with
sales for same quarter of the prior year of $8,141,000, an increase of
$1,250,000 or 15%. In the first quarter of 2000, sales increased in all of our
markets. Sales in the United States, Canada and other international markets
increased $470,000, $615,000 and $165,000, respectively. The sales increase in
the United States resulted from continued growth in the United States
distributor base that began in late 1997. The increase in Canadian sales was
primarily related to increased sales in Eastern Canada. Prior to mid-1999, our
sales were heavily concentrated in Western Canada. However, during the second
quarter of 1999, we attracted a distributor group in Eastern Canada that
continues to grow rapidly. The increase in sales in our other international
markets related to the initiation of operations by our licensees in Austria,
Australia and Russia, and increased sales by our licensee in Sweden.
Our cost of goods sold for the quarter ended March 31, 2000 was $2,293,000
compared with cost of goods sold in the same quarter of the prior year of
$1,965,000 an increase of $328,000 or 17%. As a percentage of sales, cost of
goods sold in 2000 and 1999 was 24%.
Our distributor commissions for the quarter ended March 31, 2000 were $4,090,000
compared with distributor commissions in the same quarter of 1999 of $3,448,000,
an increase of $642,000 or 19%. As a percentage of sales, distributor
commissions in 2000 were 44% compared with 42% in 1999. The increase in
distributor commissions as a percentage of sales was primarily attributable to
an increase in the percentage of our distributors who qualified to receive
maximum commission percentages under our distributor compensation plan.
Our general and administrative expenses for the quarter ended March 31, 2000,
were $2,779,000 compared with such expenses in the same quarter of 1999 of
$2,322,000, an increase of $457,000 or 20%. As percentage of sales, general and
administrative expenses were 30% in the first quarter of 2000 compared with 29%
in the comparable 1999 quarter. A significant portion of this increase
represented expenses we incurred to support the increase in our distributor base
in Eastern Canada and our new international licensees.
Our income from continuing operations for the quarter ended March 31, 2000 was
$151,000 compared with income from continuing operations in the same quarter of
the prior year of $215,000, a decrease of $64,000. This decrease was the result
of the factors previously described.
Discontinued operations represent the operations of Great Xpectations. Income
from discontinued operations was $131,000 for the quarter ended March 31, 1999.
This income resulted from the reversal of certain liabilities recorded in prior
years that were settled for less than the original contractual commitment.
-11-
<PAGE> 12
Our net income for the quarter ended March 31, 2000 was $151,000, or $.01 per
share, compared with net income in the comparable quarter of the prior year of
$346,000, a decrease of $195,000. This decline was mainly the result of the
income from discontinued operations in 1999.
There have been no economic events or changes that have affected our sales or
operating results and we are not aware of any economic trends or uncertainties
that would have a material impact on our future sales or operating results. We
believe that we have purchased our products at the best price available and that
any price increases in the foreseeable future will be small. Any such price
increases would be passed through to our customers. In addition, we do not
believe at this time that inflation will have a material impact on our operating
results.
LIQUIDITY AND CAPITAL RESOURCES
During the first three months of 2000, we had a net increase in cash of
$377,000. This increase in cash resulted primarily from net cash provided by
operating activities of $464,000, and $236,000 in net proceeds from borrowings,
that was partially offset by the net cash used to purchase property and
equipment of $151,000 and payments of long term debt and capital leases of
$174,000. The net cash provided by operations was primarily the result of an
increase in accounts payable and accrued liabilities (mainly accounts payable
and accrued distributor commissions) of $619,000 that was partially offset by an
increase in inventory of $421,000. This increase in inventory was related to the
sales increase experienced by the Company.
Consistent with industry practice, most of our sales are paid at the time of
order. Therefore, our primary working capital need is to fund increases in
inventory required to support sales growth. Since our sales are generated
through independent distributors who do not maintain a significant inventory, it
is necessary for us to have products on hand when the distributors place their
orders. During periods of sales growth we must purchase inventory in
anticipation of sales, thereby creating the need for additional working capital.
We believe that we will be able to fund further moderate sales increases through
our operations. Should sales growth increase beyond our ability to finance our
growth internally, we will again seek outside sources of capital including bank
borrowings, other types of debt financing, or an equity offering. There is no
assurance, however, that we would be able to obtain any additional outside
financing.
During the remainder of 2000, we will require additional capital to complete the
upgrade of the software used to manage our distributor network. We plan to
finance the completion of these upgrades through cash flow from operations and
existing credit lines. We have no plans or requirements for any other
significant capital expenditures during the next twelve months.
Other than those factors already described, we are not aware of any trends or
uncertainties that would significantly effect our liquidity or capital resources
in the future.
-12-
<PAGE> 13
ITEM 3. Quantitative and Qualitative Disclosure about Market Risk
Not Applicable
-13-
<PAGE> 14
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
None
Item 2. Changes in Securities.
None
Item 3. Defaults Upon Senior Securities.
None
Item 4. Submission of Matters to a Vote of Security Holders.
None
Item 5. Other Information.
None
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibits
27 Financial Data Schedule
27.1 Restated Financial Data Schedule
(b) Reports on Form 8-K
None
-14-
<PAGE> 15
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Royal BodyCare, Inc.
--------------------
Registrant
By: /s/ Clinton H. Howard
-------------------------------
Its: President
DATE: May 15, 2000
Irving, Texas
<PAGE> 16
EXHIBIT INDEX
<TABLE>
<CAPTION>
EXHIBIT NUMBER DESCRIPTION
- -------------- -----------
<S> <C>
27 Financial Data Schedule
27.1 Restated Financial Data Schedule
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> MAR-31-2000
<CASH> 585,228
<SECURITIES> 0
<RECEIVABLES> 708,383
<ALLOWANCES> 75,000
<INVENTORY> 3,321,838
<CURRENT-ASSETS> 4,792,018
<PP&E> 3,600,210
<DEPRECIATION> 1,251,714
<TOTAL-ASSETS> 9,951,315
<CURRENT-LIABILITIES> 4,632,848
<BONDS> 746,168
0
0
<COMMON> 13,916
<OTHER-SE> 4,526,848
<TOTAL-LIABILITY-AND-EQUITY> 9,951,315
<SALES> 9,390,527
<TOTAL-REVENUES> 9,390,527
<CGS> 2,293,157
<TOTAL-COSTS> 2,293,157
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 41,019
<INCOME-PRETAX> 228,982
<INCOME-TAX> 78,000
<INCOME-CONTINUING> 150,982
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 150,982
<EPS-BASIC> .01
<EPS-DILUTED> .01
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<RESTATED>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> MAR-31-1999
<CASH> 473,155
<SECURITIES> 0
<RECEIVABLES> 491,010
<ALLOWANCES> 25,000
<INVENTORY> 2,712,217
<CURRENT-ASSETS> 3,965,814
<PP&E> 2,304,050
<DEPRECIATION> 905,712
<TOTAL-ASSETS> 8,206,954
<CURRENT-LIABILITIES> 3,376,915
<BONDS> 364,555
0
0
<COMMON> 13,862
<OTHER-SE> 4,394,842
<TOTAL-LIABILITY-AND-EQUITY> 4,408,704
<SALES> 8,141,320
<TOTAL-REVENUES> 8,141,320
<CGS> 1,965,432
<TOTAL-COSTS> 1,965,432
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 28,095
<INCOME-PRETAX> 404,913
<INCOME-TAX> 190,000
<INCOME-CONTINUING> 214,913
<DISCONTINUED> 131,433
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 346,346
<EPS-BASIC> .02
<EPS-DILUTED> .02
</TABLE>
